. 2017 Oct 31;12(10):e0186614. doi: 10.1371/journal.pone.0186614

Table 3. Summary of the CRISPR Cas9 transfection and characterization experiments.

	IRAK1^-	IRAK4^-	TLR9^-	MyD88^-	Akata px458-ctl
Inactive TLR9 pathway (ko)	13/23^a	4/10^a	5/10^a	6/10^a	0/12^a
EBV positive	7/23^b	6/10^b	6/10^b	9/10^b	10/12^b
EBV positive / TLR9 ko	0/13^c	3/4^c	3/5^c	5/6^c	0/0^c

^a = number of single cell clones with an inactive TLR9 pathway over the total number of single cell clones analyzed

^b = number of EBV positive single cell clones over the total number of single cell clones analyzed

^c = number of EBV positive single cell clones over the number of single cell clones with an inactive TLR9 pathway.